Grants / Department of Health and Human Services / Centers for Disease Control and Prevention - ERA

RFA-PS-22-001: Implementing Pre-exposure Prophylaxis for HIV Prevention in Syringe Service Programs

Closed Closed January 18, 2022 Opportunity RFA-PS-22-001 ☆ Save

This grant is closed. A newer notice from the same program is open now: NIH, CDC and FDA Small Business Innovation Research Grant (Parent SBIR [R43/R44] Clinical Trial Optional) (PA-27-100). Status: Due dates in the notice, expires April 5, 2027. It is in our archive of Centers for Disease Control and Prevention - ERA notices from 2021.

• Award ceiling$625,000
• Award floor$500,000
• Total funding$2.5 million
• Expected awards1
• Cost sharingNot required
• Funding typeCooperative Agreement

Key dates

Who can apply

This opportunity was open to nonprofits, colleges and universities, state and local governments, tribes, small businesses and businesses.

The following types of Higher Education Institutions are always encouraged to apply for CDC support as Public or Private Institutions of Higher Education: Hispanic-serving Institutions Historically Black Colleges and Universities (HBCUs) Tribally Controlled Colleges and Universities (TCCUs) Alaska Native and Native Hawaiian Serving Institutions Nonprofits (Other than Institutions of Higher Education) Eligible Agencies of the Federal Government Faith-based or Community-based Organizations U.S. Territory or Possession Regional Organizations Bona Fide Agents: A Bona Fide Agent is an agency/organization identified by the state as eligible to submit an application under the state eligibility in lieu of a state application. If applying as a bona fide agent of a state or local government, a legal, binding agreement from the state or local government as documentation of the status is required. Attach with "Other Attachment Forms" when submitting via https://www.grants.gov Federally Funded Research and Development Centers (FFRDCs): FFRDCs are operated, managed, and/or administered by a university or consortium of universities, other not-for-profit or nonprofit organization, or an industrial firm, as an autonomous organization or as an identifiable separate operating unit of a parent organization. A FFRDC meets some special long-term research or development need which cannot be met as effectively by an agency’s existing in-house or contractor resources. FFRDC’s enable agencies to use private sector resources to accomplish tasks that are integral to the mission and operation of the sponsoring agency. For more information on FFRDCs, go to https://gov.ecfr.io/cgi-bin/searchECFR

More grants for nonprofits, colleges and universities, state and local governments, tribes, small businesses, businesses.

Is this a realistic fit?

• No cost sharing or match is required.

What the grant funds

The purpose of this Notice of Funding Opportunity (NOFO) is to support implementation research on combining HIV prevention modalities to add navigation for HIV pre-exposure prophylaxis (PrEP) at syringe service programs (SSPs) for people who inject drugs (PWID). The recipient should be an organization or institution that includes or partners with multiple and diverse SSPs. CDC is interested in increasing PrEP care through SSPs by incorporating more PrEP navigation and support into standard processes. The NOFO seeks effectiveness-implementation research on the acceptability and feasibility of a navigator-enhanced PWID PrEP service bundle at SSPs and optimizing it for initiation and retention in PrEP care among adult PWID. Applied research resulting from this funding is expected to strengthen combined HIV prevention for PWID and is aligned with the HIV National Strategic Plan (2021-2025) and the Ending the HIV Epidemic in the U.S. (EHE) initiative “Prevent” Pillar.

Category: Health.

Applying now

This notice no longer takes applications. Apply under the newer notice, PA-27-100, which is open now.

The notice on Grants.gov keeps its full text and attachments, which is useful for planning a resubmission.